English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Department of Dermatology, University Hospital of Nice, Nice, France; 3LEO Pharma A/S, Ballerup, Denmark; 4Lynde Dermatology, Probity Medical Research, Markham, ON, Canada; 5Department of Medicine, University of Toronto, Toronto, ON, Canada; 6Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany; 7Dermatology Centre, Salford Royal NHS Foundation Trust and NIHR Biomedical Research Centre, University of Manchester, Manchester, UK

skin

Safety of Long-Term Proactive Management with Fixed-Dose Combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam in Patients with Psoriasis Vulgaris: Results of a Phase III, Multicentre, Randomized, 52-Week, Vehicle-Controlled Trial